Pigmented villonodular synovitis therapy with MSCF-1 inhibitors

Current Opinion in Oncology

Volumn 24, Issue 4, 2012, Pages 404-408

  Temple, H Thomas ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

colony stimulating factor 1; imatinib; pigmented villonodular synovitis; tenosynovial giant cell tumor

Indexed keywords

COLONY STIMULATING FACTOR 1; IMATINIB; NILOTINIB; RADIOISOTOPE; SUNITINIB;

ARTHROSCOPIC SYNOVECTOMY; ARTHROTOMY; CANCER RADIOTHERAPY; CELL SUBPOPULATION; CYTOGENETICS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FLUID RETENTION; GIANT CELL TUMOR; GIANT CELL TUMOR OF TENDON SHEATH; HUMAN; NAUSEA; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SIDE EFFECT; SYNOVECTOMY; TENDON SHEATH; TOXICITY; TUMOR CELL;

ANTIBODIES, MONOCLONAL; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; PIPERAZINES; PYRIMIDINES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; SYNOVITIS, PIGMENTED VILLONODULAR;

EID: 84862144674     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e328354c16b     Document Type: Review

References (29)

1. Blay JY, El Sayadi H, Thiesse P, et al. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol 2008; 19:821-822. (Pubitemid 351461057)
2. Dewar AL, Cambareri AC, Zannettino AC, et al. Macrophage colonystimulating factor receptor c-fms is a novel target of imatinib. Blood 2005; 105:3127-3132.
3. Enzinger, Weiss. Soft Tissue Tumors. Mosby; 2008. pp. 770-787.
4. Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum 2011; 40:539-546.
5. Sharma V, Cheng EY. Outcomes after excision of pigmented villonodular synovitis of the knee. Clin Orthop Relat Res 2009; 467:2852-2858.
6. Dal Cin P, Sciot R, Samson I, et al. Cytogenetic characterization of tenosynovial giant cell tumors (nodular tenosynovitis). Cancer Res 1994; 54:3986-3987. (Pubitemid 24258097)
7. Mertens F, O ̈ rndal C, Mandahl N, et al. Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue. Genes Chromosomes Cancer 1993; 6:212-217. (Pubitemid 23111755)
8. Ohjimi Y, Iwasaki H, Ishiguro M, et al. Short arm of chromosome 1 aberration recurrently found in pigmented villonodular synovitis. Cancer Genet Cytogenet 1996; 90:80-85. (Pubitemid 26316428)
9. Nilsson, Hö glund M, Panagopoulos I, et al. Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors. Virchows Arch 2002; 441:475-480. (Pubitemid 35430463)
10. Sciot R, Rosai J, Dal Cin P, et al. Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group. Mod Pathol 1999; 12:576-579. (Pubitemid 29279709)
11. Rowlands CG, Roland B, Hwang WS, Sevick RJ. Diffuse-variant tenosynovial giant cell tumor: A rare and aggressive lesion. HumPathol 1994; 25:423-425. (Pubitemid 24151131)
12. West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giantcell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA 2006; 103:690-695. (Pubitemid 43153087)
13. Cupp JS, Miller MA, Montgomery KD, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol 2007; 31:970-976. (Pubitemid 47165154)
14. Darwish FM, Haddad WH. Giant cell tumour of tendon sheath: experience with 52 cases. Singapore Med J 2008; 49:879-882.
15. Gibbons CL, Khwaja HA, Cole AS, et al. Giant-cell tumour of the tendon sheath in the foot and ankle. J Bone Joint Surg Br 2002; 84:1000-1003.
16. Largo RD, Jung FJ, Calcagni M, Jandali AR. Multicentric localised giant cell tumour of the tendon sheath on both hands with a focal infiltration of the extensor tendon: case report and review of the literature. Handchir Mikrochir Plast Chir 2011; 43:181-185.
17. Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Curr Opin Oncol 2011; 23:361-366.
18. Rodrigues C, Desai S, Chinoy R. Giant cell tumor of the tendon sheath: a retrospective study of 28 cases. J Surg Oncol 1998; 68:100-103. (Pubitemid 28269977)
19. Savage RC, Mustafa ED. Giant cell tumor of tendon sheath (localized nodular tenosynovitis). Plastic Surg 1984; 13:205-210.
20. Ushijma M, Hashimoto H, Tsuneyoshi M, Enjoji M. Giant cell tumor of the tendon sheath (nodular tenosynovitis). A study of 207 cases to compare the large joint group with the common digit group. Cancer 1986; 57:875-884. (Pubitemid 16161072)
21. Hitora T, Yamamoto T, Akisue T, et al. Multicentric localized giant cell tumour of the tendon sheath: two separate lesions at different sites in a finger. Br J Dermatol 2002; 147:403-405.
22. Park JW. Multiple separated giant cell tumors of the tendon sheath in a thumb. J Am Acad Dermatol 2006; 54:540-542. (Pubitemid 43243466)
23. Heyd R, Micke O, Berger B, et al. Radiation therapy for treatment of pigmented villonodular synovitis: results of a national patterns of care study. Int J Radiat Oncol Biol Phys 2010; 78:199-204.
24. O'Sullivan B, Cummings B, Catton C, et al. Outcome following radiation treatment for high-risk pigmented villonodular synovitis. Int J RadiatOncol Biol Phys 1995; 32:777-786.
25. Davis AM, Sennik S, Griffin AM, et al. Predictors of functional outcomes following limb salvage surgery for lower-extremity soft tissue sarcoma. J Surg Oncol 2000; 73:206-211. (Pubitemid 30238412)
26. Zook JE, Wurtz DL, Cummings JE, Cárdenes HR. Intra-articular chromic phosphate (32P) in the treatment of diffuse pigmented villonodular synovitis. Brachytherapy 2011; 10:190-194.
27. Cassier PA, Gelderblom H, Stacchiotti S, et al. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer 2012; 118:1649-1655.
28. Mö ller E, Mandahl N, Mertens F, Panagopoulos I. Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors. Genes Chromosomes Cancer 2008; 47:21-25. (Pubitemid 350191460)
29. Cheng H, Clarkson PW, Gao D, et al. Therapeutic antibodies targeting CSF1 impede macrophage recruitment in a xenograft model of tenosynovial giant cell tumor. Sarcoma 2010; 2010:174528.